Sequent Scientific’s wholly owned subsidiary, Alivira Animal Health (Alivira), has entered into an agreement to acquire 60% stake in Provet Veterinary Products, Turkey (Provet). The transaction is expected to close in October 2014, and is subject to customary closing conditions. The promoter of Provet is holding the balance 40% stake and will be part of the Management team at Alivira.
Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.
